sdottir I, Massague J. Cloning of p57kip2, a cyclin-dependent kinase inhibitor with unique domain instructure and tissued distribution [J]. Genes Dev, 1995, 9(6):639-649.
[6]Lai S, Goepfert H, Gillenwater AM, et al. Loss of imprinting and genetic alterations of the cyclin-dependent kinase inhibitor p57kip2 gene in head and neck squamous cell carcinoma [J]. Clin Cancer Res, 2000, 6(8):3172-3176.
[7]Nakai S, Masaki T, Shiratori Y, et al. Expression of p57(kip2) in hepatocellular carcinoma: relationship between tumor differentiation and patient survival [J]. Int J Oncol, 2002, 20(4):769-775.
[8]Huang ZY, Wu Y, Hedrick N, et al. T-cadherin-mediated cell growth regulation involves G2 phase arrest and requires p21(CIP1/WAF1) expression [J]. Mol Cell Biol, 2003, 23(2):566-578.
[9]Weng MS, Ho YS, Lin JK. Chrysin induces G1 phase cell cycle arrest in C6 glioma cells through inducing p21Waf1/Cip1 expression: involvement of p38 mitogen-activated protein kinase [J]. Biochem Pharmacol, 2005, 69(12):1815-1827.
[10]Mitani Y, Oue N, Hamai Y, et al. Histone H3 acetylation is associated with reduced p21 (WAF1/CIP1) expression by gastric carcinoma [J]. J Pathol, 2005, 205(1):65-73.
[11]Dosaka-Akita H, Hommura F, Mishina T. A Risk-stratification model of non-small cell lung cancers using cyclin E, Ki-67, and ras p21 [J]. Cancer Res, 2001, 61(6):2500-2504.
上一页 [1] [2] [3] [4]
您现在的位置： 绿色健康网 >> 医学论文 >> 外科论文 >> 正文